Pyrophosphate study in children with kidney disease
Part of Kidney & urinary clinical trials.
This study looks at a natural chemical in the body called pyrophosphate (PPi) in children with chronic kidney disease. It aims to understand how kidney problems affect this chemical, which is important for bone health. The study needs kids with different kidney stages, including those on dialysis, with a transplant, or even healthy kids having surgery for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old
- You or your parent can sign a consent form, and you are covered by health insurance
- You do NOT have an active cancer or a quickly worsening kidney disease
- You are not on medications like bisphosphonates that affect pyrophosphate (or you can stop them safely)
- You either have healthy kidneys (and are having routine surgery), or have been on dialysis for over 3 months, or have a kidney transplant, or have chronic kidney disease (any cause)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a substance in the blood called pyrophosphate that may help doctors detect a type of artery hardening (mediacalcinosis) in people with type 2 diabetes. It tests whether this substance can be a useful early warning sign.
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
This study uses a special MRI scan to look at phosphorus levels in the muscles of people with phosphate diabetes (a condition where the body loses too much phosphate through the kidneys). It aims to better understand how this condition affects muscles and may help guide future treatments.
This early study looks at how the body’s handling of phosphate may affect aging and bone health. It is meant for people with certain rare genetic conditions that change phosphate levels, to better understand their biology and responses to study tests.
This study follows people who already have hypophosphatasia (HPP) to better understand how the condition changes over time. It may help doctors recognize patterns and improve care, even if you are not receiving a new treatment.
This study checks how kidney disease affects bone health by measuring hormones like PTH and related blood markers. It may help doctors better diagnose bone problems that can occur with poor kidney function.
Hear when a new Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.